Clinical trial NCT04233970 - References

Multiple Sclerosis, Relapsing-Remitting — Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis

Citation(s)

•   Ajzen I
  The theory of planned behaviour: reactions and reflections. Psychol Health. 2011 Sep;26(9):1113-27. doi: 10.1080/08870446.2011.613995.
•   Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance
  Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.
•   Gold SM, Heesen C, Schulz H, Guder U, Monch A, Gbadamosi J, Buhmann C, Schulz KH
  Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler. 2001 Apr;7(2):119-30. doi: 10.1177/135245850100700208.
•   Hawkins RP, Kreuter M, Resnicow K, Fishbein M, Dijkstra A
  Understanding tailoring in communicating about health. Health Educ Res. 2008 Jun;23(3):454-66. doi: 10.1093/her/cyn004. Epub 2008 Mar 17.
•   Heesen C, Kasper J, Segal J, Kopke S, Muhlhauser I
  Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler. 2004 Dec;10(6):643-50. doi: 10.1191/1352458504ms1112oa.
•   Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X
  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
•   Kasper J, Kopke S, Fischer K, Schaffler N, Backhus I, Solari A, Heesen C
  Applying the theory of planned behaviour to multiple sclerosis patients' decisions on disease modifying therapy--questionnaire concept and validation. BMC Med Inform Decis Mak. 2012 Jul 2;12:60. doi: 10.1186/1472-6947-12-60.
•   Kopke S, Kasper J, Muhlhauser I, Nubling M, Heesen C
  Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Mult Scler. 2009 Jan;15(1):96-104. doi: 10.1177/1352458508095921. Epub 2008 Oct 9.
•   Kopke S, Kern S, Ziemssen T, Berghoff M, Kleiter I, Marziniak M, Paul F, Vettorazzi E, Pottgen J, Fischer K, Kasper J, Heesen C
  Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):411-8. doi: 10.1136/jnnp-2013-306441. Epub 2013 Oct 8.
•   Kopke S, Richter T, Kasper J, Muhlhauser I, Flachenecker P, Heesen C
  Implementation of a patient education program on multiple sclerosis relapse management. Patient Educ Couns. 2012 Jan;86(1):91-7. doi: 10.1016/j.pec.2011.03.013. Epub 2011 Apr 19.
•   Kurtzke JF
  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
•   Stepleman L, Rutter MC, Hibbard J, Johns L, Wright D, Hughes M
  Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disabil Rehabil. 2010;32(19):1558-67. doi: 10.3109/09638280903567885.
•   Zigmond AS, Snaith RP
  The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
•   Zill JM, Dwinger S, Kriston L, Rohenkohl A, Harter M, Dirmaier J
  Psychometric evaluation of the German version of the Patient Activation Measure (PAM13). BMC Public Health. 2013 Oct 30;13:1027. doi: 10.1186/1471-2458-13-1027.

Development and Evaluation of an Interactive Web-based Programme on Relapse Management for People With Multiple Sclerosis - a Randomized Controlled Trial With Mixed Methods Process Evaluation

Details for clinical trial NCT04233970